Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07797855 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to See How Safe a New Medicine (NNC0705-0002) is in Healthy People

StatusNot Yet Recruiting
PhasePhase 1
Started2026-09-02
View on ClinicalTrials.gov ↗
This study is testing NNC0705-0002, a new medicine that is being developed for conditions where inflammation may contribute to heart and metabolic health problems. The purpose of this study is to assess the safety, tolerability, pharmacokinetics, target engagement, and metabolism of NNC0705-0002 after single and multiple doses in healthy adults. NNC0705-0002 or a placebo (a substance that looks like the study medicine but contains no active medicine), and the treatment they receive may be chosen by chance. NNC0705-0002 is a new medicine that is not yet approved for doctors to prescribe. Depending on the part of the study, participation may last for up to about 7 weeks, including screening, treatment, and follow-up visits.
Trial Details
NCT Number NCT07797855
Lead Sponsor Novo Nordisk A/S
Conditions Healthy Volunteers, Cardiometabolic Diseases
Enrollment 112 participants
Start Date 2026-09-02
Primary Completion 2027-08-01 (estimated)
Study Completion 2027-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-09-01